In Germany, Alzheimer’s disease and its related conditions – collectively known as dementia – are a major health concern, affecting roughly 1.8 million people.
Alzheimer’s can cause memory loss, create confusion, and alter behavior, making day-to-day living a challenge for those affected.
While scientists have a general understanding of the disease, pinpointing its exact causes has proven elusive. Although genetics appear to play a vital role, a comprehensive picture has yet to emerge.
Professor Dr. Lars Bertram and his team embarked on a unique research journey to shed more light on this devastating disease.
Innovative Approach to Unraveling Alzheimer’s
Typical analyses of Alzheimer’s have employed a method known as a “case-control design,” essentially comparing people with the disease to those without.
However, Dr. Bertram noted that this common strategy, although useful, often neglects a wealth of clinical information that could potentially unlock new understandings of Alzheimer’s mechanisms.
In their recent study, involving close to a thousand individuals and published in Genome Medicine, the team amalgamated data from six Alzheimer’s biomarkers, providing a much more detailed and precise depiction of the disease’s genetic impact.
A significant discovery from the study pertains to GRIN2D, a receptor in our brain related to the neurotransmitter glutamate.
The research found its expression to be diminished in Alzheimer’s patients, which Dr. Bertram indicates likely impairs synapses – the structures that allow nerve cells to communicate with each other.
Two Pathways and Gender Disparities
The study not only delved into genetic influences but also enabled additional analyses due to the incorporation of multiple biomarkers.
Dr. Alexander Neumann explained that they utilized mediation analyses, a statistical technique designed to unearth possible causal relationships between the studied biomarkers and the disease itself.
Two main pathways were identified: the first involves amyloid and tau proteins and the well-known Alzheimer’s risk gene APOE, while the second major pathway predominantly pertains to immune system responses, influenced in part by genes such as TMEM106B and CHI3L1.
A fascinating dimension of the research explored the role of the X chromosome and illuminated previously uncharted territories regarding the disparate prevalence of Alzheimer’s between men and women.
Dr. Olena Ohlei shared that certain genes exhibit measurable effects related to Alzheimer’s biomarkers exclusively in men or women, with some even exerting opposing effects between the genders.
Future Directions and Early Diagnosis Possibilities
This groundbreaking study not only adds to the repository of knowledge surrounding Alzheimer’s but also points towards innovative approaches for better understanding and potentially diagnosing the disease.
Dr. Bertram emphasized that the methodology of multivariate analysis (analyzing several biomarkers together) could eventually enhance diagnostic capabilities or even facilitate earlier diagnosis of Alzheimer’s.
Yet, to further cement these findings and potential methodologies, more research and validation are required.
In the world of science, every new discovery brings hope and closer to understanding complex diseases like Alzheimer’s.
This novel approach, diving deep into genetic analysis, offers a fresh perspective and a new direction, which might eventually lead to enhanced diagnostic methods and further our understanding of the mechanisms underlying Alzheimer’s, potentially paving the way toward improved management and treatment strategies in the future.
If you care about Alzheimer’s, please read studies about Vitamin D deficiency linked to Alzheimer’s, vascular dementia, and Oral cannabis extract may help reduce Alzheimer’s symptoms.
For more information about brain health, please see recent studies about Vitamin B9 deficiency linked to higher dementia risk, and results showing flavonoid-rich foods could improve survival in Parkinson’s disease.
The research findings can be found in Genome Medicine.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.